Ally Olotu/Lancet Infect Dis
2 results
Efficacy of RTS,S malaria vaccines: individual-participant pooled analysis of phase 2 data.Bejon, P.
White, M. T.
Olotu, A.
Bojang, K.
Lusingu, J. P.
Salim, N.
Otsyula, N. N.
Agnandji, S. T.
Asante, K. P.
Owusu-Agyei, S.
Abdulla, S.
Ghani, A. C.
Lancet Infect Dis, (2013). 13:319-27
Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trial.Olotu, A.
Lusingu, J.
Leach, A.
Lievens, M.
Vekemans, J.
Msham, S.
Lang, T.
Gould, J.
Dubois, M. C.
Jongert, E.
Vansadia, P.
Carter, T.
Njuguna, P.
Awuondo, K. O.
Malabeja, A.
Abdul, O.
Gesase, S.
Mturi, N.
Drakeley, C. J.
Savarese, B.
Villafana, T.
Lapierre, D.
Ballou, W. R.
Cohen, J.
Lemnge, M. M.
Peshu, N.
Marsh, K.
Riley, E. M.
von Seidlein, L.
Bejon, P.
Lancet Infect Dis, (2011). 11:102-9